Advertisement

Perspective

  • Thomas Muehlberger
Chapter

Abstract

Major innovations sometimes develop akin to the process from crawling to walking to running. Migraine surgery is currently in the walking stage. The answer to the question “how do you run a marathon?” is to take one step and then another one and so on.

References

  1. 1.
    Hwang L, Dessouky R, Xi Y, Amirlak B, Chhabra A. MR neurography of greater occipital nerve neuropathy: initial experience in patients with migraine. AJNR Am J Neuroradiol. 2017;38(11):2203–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Shevel E. Craniomandibular muscles, intraoral orthoses and migraine. Expert Rev Neurother. 2005;5:371–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Medawar PB. Advice to a young scientist. New York, NY: Joanna Cotler Books; 1979. p. 73.Google Scholar
  4. 4.
    Edvinsson L, Warfvinge K. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia. 2017.  https://doi.org/10.1177/0333102417736900.
  5. 5.
    Miller S, Sinclair AJ, Davies B, Matharu M. Neurostimulation in the treatment of primary headaches. Pract Neurol. 2016;16:362–75.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155:108–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Schwedt TJ, Green AL, Dodick DW. Occipital nerve stimulation for migraine: update from recent multicenter trials. Prog Neurol Surg. 2015;29:117–26.PubMedGoogle Scholar
  8. 8.
    Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine: ONSTIM feasibility study. Cephalalgia. 2011;31:271–85.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Silberstein SD, Dodick DW, Saper jR, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine; results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32:1165–79.CrossRefPubMedGoogle Scholar
  10. 10.
    Bogduk N. The anatomy of occipital neuralgia. Clin Exp Neurol. 1980;17:167–84.Google Scholar
  11. 11.
    Bogduk N. The clinical anatomy of the cervical dorsal rami. Spine (Phila Pa 1976). 1982;7:319–30.CrossRefGoogle Scholar
  12. 12.
    Baumel JJ. Trigeminal-facial nerve communications. Their function in facial muscle innervations and reinnervation. Arch Otolaryngol. 1974;99:34–44.CrossRefPubMedGoogle Scholar
  13. 13.
    Hwang K, Han JY, Battuvshin D, et al. Communication of infraorbital nerve and facial nerve: anatomic and histologic study. J Craniofac Surg. 2004;15:88–91.CrossRefPubMedGoogle Scholar
  14. 14.
    Kwak HH, Park HD, Youn KH, et al. Branching patterns of the facial nerve and its communication with the auriculotemporal nerve. Surg Radiol Anat. 2004;26:494–500.CrossRefPubMedGoogle Scholar
  15. 15.
    Namking M, Boonruangsri P, Woraputtaporn W, Guldner FH. Communication between the facial and auriculotemporal nerves. J Anat. 1994;185:421–6.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Tohma A, Mine K, Tamatsu Y, et al. Communication between the buccal nerve (V) and facial nerve (VII) in the human face. Ann Anat. 2004;186:173–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Lous I, Olesen J. Evaluation of pericranial tenderness and oral function in patients with common migraine, muscle contraction headache and ‘combination headache’. Pain. 1982;12:385–93.CrossRefPubMedGoogle Scholar
  18. 18.
    Lamey PJ, Burnett CA, Fartash L, Clifford TJ, McGovern JM. Migraine and masticatory muscle volume, bite force, and craniofacial morphology. Headache. 2001;41:49–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Didier H, Marchetti C, Marchetti A, D’Amico D, Tullo V, Bussone G, Santoro F. Implementing gnathological and neuromuscular concepts in patients with chronic migraine. Neurol Sci. 2012;33:177–80.CrossRefGoogle Scholar
  20. 20.
    Bevilaqua Grossi D, Lipton RB, Bigal ME. Temporomandibular disorders and migraine chronification. Curr Pain Headache Rep. 2009;13:314–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Franco AL, Gonçalves DA, Castanharo SM, et al. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010;24:287–92.PubMedGoogle Scholar
  22. 22.
    Hu JW, Sessle BJ, Raboisson P, Dallel R, Woda A. Stimulation of craniofacial muscle afferents induces prolonged facilitatory effects in trigeminal nociceptive brain-stem neurones. Pain. 1992;48:53–60.CrossRefPubMedGoogle Scholar
  23. 23.
    Shankland WE. Nociceptive trigeminal inhibition-tension suppression system: a method of preventing migraine and tension headaches. Compend Contin Educ Dent. 2002;23:105–8.PubMedGoogle Scholar
  24. 24.
    Steele JG, Lamey PJ, Sharkey SW, Smith GM. Occlusal abnormalities, pericranial muscle and joint tenderness and tooth wear in a group of migraine patients. J Oral Rehabil. 1991;18:453–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Lamey PJ, Barclay SC. Clinical effectiveness of occlusal splint therapy in patients with classical migraine. Scott Med J. 1987;32:11–2.CrossRefPubMedGoogle Scholar
  26. 26.
    Lapeer GL. Reduction of the painful sequelae of migraine headache by use of the occlusal diagnostic splint: an hypothesis. Cranio. 1988;6:82–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Quayle AA, Gray RJ, Metcalfe RJ, Guthrie E, Wastell D. Soft occlusal splint therapy in the treatment of migraine and other headaches. J Dent. 1990;18:123–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Cooper BC, Kleinberg I. Relationship of temporomandibular disorders to muscle tension-type headaches and a neuromuscular orthosis approach to treatment. Cranio. 2009;27:101–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 2011;76:1135–8.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Novack V, Fuchs L, Lantsberg L, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31:1336–42.CrossRefPubMedGoogle Scholar
  31. 31.
    Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache: Part I - A systematic review of the epidemiology of obesity and headache. Headache. 2014;54:219–34.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia. 2008;28:1270–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Chai NC, Bond DS, Moghekar A, Scher AI, Peterlin BL. Obesity and headache: Part II - Potential mechanism and treatment considerations. Headache. 2014;54:459–71.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache. 2010;50:631–48.CrossRefPubMedGoogle Scholar
  35. 35.
    Rothrock JF. Through thick and thin. Headache. 2010;50:649.CrossRefPubMedGoogle Scholar
  36. 36.
    Young WB, Rozen TD. Preventive treatment of migraine: effect on weight. Cephalalgia. 2005;25:1–11.CrossRefPubMedGoogle Scholar
  37. 37.
    Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8:327–30.CrossRefPubMedGoogle Scholar
  38. 38.
    Kutty S, Sengupta PP, Khandheria BK. Patent foramen ovale: the known and the to be known. J Am Coll Cardiol. 2012;59:1665–71.CrossRefPubMedGoogle Scholar
  39. 39.
    Wahl A, Praz F, Tai T, et al. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2010;96:967–73.CrossRefPubMedGoogle Scholar
  40. 40.
    Rigatelli G, Dell'avvocata F, Cardaioli P, et al. Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up. Am J Cardiovasc Dis. 2012;2:89–95.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397–404.CrossRefPubMedGoogle Scholar
  42. 42.
    Schuerks M, Diener HC. Closure of patent foramen ovale in the prevention of migraine: not enough evidence in favor. Nat Clin Pract Neurol. 2009;5:22–3.CrossRefGoogle Scholar
  43. 43.
    Tfelt-Hansen PC, Koehler PJ. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache. 2011;51:752–78.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Thomas Muehlberger
    • 1
  1. 1.Medsteps AGChamSwitzerland

Personalised recommendations